Vivani Medical Inc. (VANI)
1.07
-0.04 (-3.60%)
At close: Mar 31, 2025, 12:32 PM
Vivani Medical Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | n/a | n/a | n/a | n/a | 3.38M | 6.9M | 7.96M | 3.98M | 8.95M | 3.4M | 1.56M | 1.37M |
| Cost of Revenue | 357K | 381K | 345K | 167K | 2.15M | 4.89M | 7.75M | 9.35M | 4.3M | 3.56M | 5.63M | 4.4M |
| Gross Profit | -357K | -381K | -345K | -167K | 1.23M | 2.01M | 211K | -5.36M | 4.65M | -160.28K | -4.06M | -3.03M |
| Operating Income | -26.96M | -21.24M | -13.32M | -9.24M | -30.6M | -34.83M | -28.71M | -33.21M | -20.05M | -21.23M | -18M | -16.02M |
| Interest Income | n/a | n/a | n/a | 16K | 362K | 86K | 93K | 31K | 2K | 9.11K | 7.45K | 7.51K |
| Pretax Income | -25.65M | -13.89M | -12.77M | -9.28M | -33.59M | -35.09M | -28.52M | -33.18M | -20.02M | -35.2M | -22.97M | -16.28M |
| Net Income | -25.65M | -6.54M | -12.13M | -9.28M | -33.59M | -35.09M | -28.52M | -33.18M | -20.02M | -35.2M | -22.97M | -16.28M |
| Selling & General & Admin | 10M | 7.07M | 2.32M | 2.38M | 15.33M | 26.63M | 23.56M | 21.77M | 20.67M | 13.41M | 7.47M | 6.22M |
| Research & Development | 16.97M | 14.17M | 11M | 6.87M | 16.5M | 10.21M | 7.99M | 5.35M | 3.04M | 5.04M | 3.25M | 3.05M |
| Other Expenses | n/a | 475K | -91K | -36K | 3.35M | 4.6M | 2.64M | -727K | -991K | 2.62M | 3.22M | 3.73M |
| Operating Expenses | 26.96M | 21.24M | 13.32M | 9.24M | 31.82M | 36.83M | 28.92M | 27.85M | 24.7M | 21.07M | 13.93M | 12.99M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 29K | 7.03M | 5.01M | 267.03K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 6.1M | 11.34M | 9.57M | 8.99M | 8.94M | 6.84M | 3.3M | 2.19M |
| Cost & Expenses | 26.96M | 21.24M | 13.32M | 9.24M | 33.98M | 41.72M | 36.67M | 37.2M | 29M | 24.63M | 19.56M | 17.39M |
| Income Tax | n/a | -7.35M | -641K | 147.7K | 362K | 86K | 93K | 31K | 58K | -6.93M | 42.22K | 9.29K |
| Shares Outstanding (Basic) | 50.85M | 38.24M | 11.03M | 6.86M | 4.9M | 2.77M | 2.26M | 1.65M | 1.48M | 3.41M | 4.72M | 4.72M |
| Shares Outstanding (Diluted) | 50.85M | 38.24M | 11.03M | 6.86M | 4.9M | 2.77M | 2.26M | 1.65M | 1.48M | 3.41M | 4.72M | 4.72M |
| EPS (Basic) | -0.5 | -0.17 | -1.1 | -1.35 | -6.85 | -12.69 | -12.64 | -20.13 | -13.48 | -10.31 | -4.87 | -3.45 |
| EPS (Diluted) | -0.5 | -0.17 | -1.1 | -1.35 | -6.85 | -12.69 | -12.64 | -20.13 | -13.48 | -10.31 | -4.87 | -3.45 |
| EBITDA | -26.61M | -19.16M | -12.98M | -8.89M | -33.18M | -34.66M | -28.06M | -32.75M | -19.68M | -27.89M | -17.64M | -15.69M |
| Depreciation & Amortization | 357K | 381K | 345K | 167K | 414K | 435K | 457K | 432K | 335K | 279.18K | 315.77K | 324.71K |